Company research
BioPlus Acquisition Corp.
CIK 1856653Updated Sep 24, 2026
Securities
BIOS price & chart
Historical security
This listing closed Oct 6, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 238,324,586Source | 235,980,915Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 635,542Source |
| Assets, CurrentUSD | 548,763Source | 1,002,286Source |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 15,326,875Source | 14,979,136Source |
| Stockholders’ equity: | ||
| Retained Earnings (Accumulated Deficit)USD | -14,778,743Source | 13,598,852Source |
| Stockholders' Equity Attributable to ParentUSD | -14,778,112Source | -13,598,221Source |
| Liabilities and EquityUSD | 238,324,586Source | 235,980,915Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 526,875Source | 179,136Source |
| Additional Financial Items | ||
| Accrued Liabilities, CurrentUSD | 263,150Source | 111,636Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -691,465Source | -773,937Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 0Source | -234,600,000Source |
| Cash flows from financing activities: | ||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 196,225Source | 236,009,479Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -495,240Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 140,302Source | — |
| Additional Financial Items | ||
| Net Income (Loss) Attributable to ParentUSD | 1,995,932Source | -140,200Source |
| Proceeds from Issuance of Common StockUSD | — | 25,000Source |